Our findings reveal a vascular-specific enhancer network through which noncoding variation at 9p21.3 modulates CAD risk via MTAP—a previously unrecognized regulator of vascular remodeling located 269 kb from the risk haplotype. The gene discussed is MTAP; the disease is coronary artery disorder.